Similar to GBM, tGLI1 is expressed in a tumor specific pattern, i.e., observed only in malignant breast tissue and cells, and transactivates novel target genes not regulated by GLI1 to promote aggressive phenotypes [24,25,28,30,31]. The gene discussed is GLI1; the disease is neoplasm.